Effects of idazoxan on dopamine release in the prefrontal cortex of freely moving rats

European Journal of Pharmacology

Volumn 343, Issue 2-3, 1998, Pages 165-170

  Matsumoto, Machiko ^a   Yoshioka, Mitsuhiro ^a   Togashi, Hiroko ^a   Mori, Kiyoshi ^a   Ueno, Ken Ichi ^a   Saito, Hideya ^b  

^a HOKKAIDO UNIVERSITY   (Japan)

^b Kinki University   (Japan)

Author keywords

5 HT (5 hydroxytryptamine serotonin); Anxiety; Cortex, prefrontal; Dopamine release; Idazoxan

Indexed keywords

5,7 DIHYDROXYTRYPTAMINE; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; ANXIOLYTIC AGENT; DESIPRAMINE; DIAZEPAM; DOPAMINE; IDAZOXAN; SEROTONIN; TROPISETRON;

ANIMAL EXPERIMENT; ANXIETY; ARTICLE; BRAIN INJURY; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC SYSTEM; DOSE TIME EFFECT RELATION; FEAR; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MICRODIALYSIS; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; SEROTONINERGIC NERVE CELL; SEROTONINERGIC SYSTEM;

5,7-DIHYDROXYTRYPTAMINE; ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; ANXIETY; DOPAMINE; IDAZOXAN; INJECTIONS, INTRAVENTRICULAR; MALE; PREFRONTAL CORTEX; RATS; RATS, WISTAR; SEROTONIN;

EID: 0032545996     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01544-6     Document Type: Article

References (36)

1. Abercrombie E.D., Keefe K.A., DiFrischia D.S., Zigmond M.J. Differential effect of stress on in vivo dopamine release in striatum, nucleus accumbens, and medial frontal cortex. J. Neurochem. 52:1989;1655-1658.
2. Bannon M.J., Michaud R.L., Roth R.H. Mesocortical dopamine neurons lack of autoreceptors modulating dopamine synthesis. Mol. Pharmacol. 19:1981;270-275.
3. Barnes N.M., Cheng C.H.K., Costall B., Ge J., Naylor R.J. Differential modulation of extracellular levels of 5-hydroxytryptamine in the rat frontal cortex by (R)- and (S)-zacopride. Br. J. Pharmacol. 107:1992;233-239.
4. Benloucif S., Keegan M.J., Galloway M.P. Serotonin-facilitated dopamine release in vivo: Pharmacological characterization. J. Pharmacol. Exp. Ther. 265:1993;373-377.
5. 3 receptors in rat striatum. J. Pharmacol. Exp. Ther. 251:1989;803-809.
6. 4 receptor subtype involvement in the enhancement of striatal dopamine release induced by serotonin: A microdialysis study in the halothane-anesthetized rat. Neuropharmacology. 34:1995;269-279.
7. Bradberry C.W., Lory J.S., Roth R.H. The anxiogenic β-carboline FG 7142 selectively increase dopamine release in the rat prefrontal cortex as measured by microdialysis. J. Neurochem. 56:1991;748-752.
8. Ceulemans D.L.S., Hoppenbrowers M.L.J.A., Gelders Y.G., Reyntjeus A.J.M. The influence of ritanserin, a serotonin antagonist, in anxiety disorders: A double-bind placebo-controlled study versus lorazepam. Pharmacopsychiatry. 18:1985;303-305.
9. Cheng C.H.K., Costall B., Ge J., Naylor R.J. The profiles of interaction of yohimbine with anxiolytic and putative anxiolytic agents to modify 5-HT release in the frontal cortex of freely-moving rats. Br. J. Pharmacol. 110:1993;1079-1084.
10. Claustre Y., Rivy J.P., Dennis T., Scatton B. Pharmacological studies on stress-induced increase in frontal cortical dopamine metabolism in the rat. J. Pharmacol. Exp. Ther. 238:1986;693-700.
11. 3 receptor agonist and antagonists for alteration of aversive behaviour in the mouse. Br. J. Pharmacol. 96:1989;325-332.
12. Descarries L., Lemay B., Doucet G., Berger B. Regional and laminar density of the dopamine innervation in adult rat cerebral cortex. Neuroscience. 21:1987;807-821.
13. 1A receptor modulation of anxiety in two ethological animal tests. J. Neuroscience. 16:1996;4810-4815.
14. 2-adrenoceptors on rat central neurons. Eur. J. Pharmacol. 105:1984;265-272.
15. Garratt J.C., Crespi F., Mason R., Marsden C.A. Effects of idazoxan on dorsal raphe 5-hydroxytryptamine neuronal function. Eur. J. Pharmacol. 193:1991;87-93.
16. Göthert, M., Schlicker, E., 1991. Regulation of serotonin release in the central nervous systems by presynaptic heteroreceptors. In: Fergerbaum, J., Hanani, M. (Eds.), A Handbook, vol. 2. Freund, Tel Aviv, pp. 845-876.
17. 3 receptor antagonists: A critical update on therapeutic potential. Trends Pharmacol. Sci. 14:1993;265-270.
18. Grenhoff J., Svensson T.H. Clonidine modulates dopamine cell firing in rat ventral tegmental area. Eur. J. Pharmacol. 165:1989;11-18.
19. Handley S.L., Mithani S. Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of 'fear'-motivated behaviour. Naunyn-Schmiedebergs Arch. Pharmacol. 327:1984;1-5.
20. 1-like and GABA receptors in the dorsal raphe nucleus of the rat. Neuropharmacology. 27:1988;993-1001.
21. Matsumoto M., Togashi H., Yoshioka N., Morii K., Hirokami M., Tochihara M., Ikeda T., Saito Y., Saito H. Significant correlation between cerebrospinal fluid and brain levels of norepinephrine, serotonin and acetylcholine in anesthetized rats. Life Sci. 48:1991;823-829.
22. Matsumoto M., Yoshioka M., Togashi H., Ikeda T., Saito H. Functional regulation by dopamine receptors of serotonin release from the rat hippocampus: In vivo microdialysis study. Naunyn-Schimideberg's Arch. Pharmacol. 353:1996;621-629.
23. Murphy B.L., Arnsten A.F.T., Jentsch J.D., Roth R.H. Dopamine and spatial working memory in rats and monkeys: Pharmacological reversal of stress-induced impairment. J. Neurosci. 16:1996;7768-7775.
24. Pei Q., Zetterstrom T., Fillenz M. Both systemic and local administration of benzodiazepine agonists inhibit the in vivo release of 5-HT from ventral hippocampus. Neuropharmacology. 28:1989;1061-1066.
25. Roth B.L., Craigo S.C., Choudhary M.S., Uluer A., Monsma F.J. Jr., Shen Y., Meltzer H.Y., Sibley D.R. Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors. J. Pharmacol. Exp. Ther. 268:1994;1403-1410.
26. Sorg B.A., Kalivas P.W. Effects of cocaine and footshock stress on extracellular dopamine levels in the medial prefrontal cortex. Neuroscience. 53:1993;695-703.
27. Starke K., Göthert M., Kilbinger H. Modulation of neurotransmitter release by presynaptic autoreceptors. Phys. Rev. 69:1989;864-989.
28. 2 receptors. J. Pharmacol. Exp. Ther. 266:1993;1374-1384.
29. 4 receptor ligands to modulate rat striatal dopamine release in vitro and in vivo. Br. J. Pharmacol. 117:1996;55-62.
30. Tam S.-Y., Roth R.H. Modulation of mesoprefrontal dopamine neurons by central benzodiazepine receptors. I. Pharmacological characterization. J. Pharmacol. Exp. Ther. 252:1990;989-996.
31. Tanda G., Carboni E., Frau R., Chiara G.D. Increase of extracellular dopamine in the prefrontal cortex: A trait of drugs with antidepressant potential? Psychopharmacology. 115:1994;285-288.
32. Trulson M.E., Preussler D.W., Howell G.A., Frederickson C.J. Raphe unit activity in freely moving cats: Effects of benzodiazepines. Neuropharmacology. 21:1982;1045-1050.
33. Ueda H., Goshima Y., Misu Y. Presynaptic mediation by α2-, β1- and β2-adrenoceptors of endogenous dopamine release from slices of rat hypothalamus. Life Sci. 33:1983;371-376.
34. Yoshioka M., Matsumoto M., Togashi H., Saito H. Effects of conditioned fear stress 5-HT release in the rat prefrontal cortex. Pharmacol. Biochem. Behav. 51:1995;515-519.
35. Yoshioka M., Matsumoto M., Togashi H., Saito H. Effect of conditioned fear stress on dopamine release in the rat prefrontal cortex. Neurosci. Lett. 209:1996;201-203.
36. Wright I.K., Heaton M., Upton N., Marsden C.A. Comparison of acute and chronic treatment of various serotonergic agents with those of diazepam and idazoxan in the rat elevated X-maze. Psychopharmacology. 107:1992;405-414.